135 related articles for article (PubMed ID: 7544737)
21. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
22. A monoclonal antibody cocktail for detection of micrometastatic tumor cells in the bone marrow of breast cancer patients.
Taha M; Ordoñez NG; Kulkarni S; Owen M; Ro JS; Hortobagyi G; Reading CL; Dicke KA; Spitzer G
Bone Marrow Transplant; 1989 May; 4(3):297-303. PubMed ID: 2471564
[TBL] [Abstract][Full Text] [Related]
23. Detection of micrometastasis of neuroblastoma to bone marrow and tumor dissemination to hematopoietic autografts using flow cytometry and reverse transcriptase-polymerase chain reaction.
Tsang KS; Li CK; Tsoi WC; Leung Y; Shing MM; Chik KW; Lee V; Ng MH; Yuen P
Cancer; 2003 Jun; 97(11):2887-97. PubMed ID: 12767104
[TBL] [Abstract][Full Text] [Related]
24. Immunocytochemistry and flow cytometry evaluation of human megakaryocytes in fresh samples and cultures of CD34+ cells.
Qiao X; Loudovaris M; Unverzagt K; Walker DE; Smith SL; Martinson J; Schilling M; Lee W; Williams SF; Van Epps DE; Cohen I; Bender JG
Cytometry; 1996 Mar; 23(3):250-9. PubMed ID: 8974870
[TBL] [Abstract][Full Text] [Related]
25. A novel HSV-1 virus, JS1/34.5-/47-, purges contaminating breast cancer cells from bone marrow.
Hu JC; Booth MJ; Tripuraneni G; Davies D; Zaidi SA; Tamburo de Bella M; Slade MJ; Marley SB; Gordon MY; Coffin RS; Coombes RC; Kamalati T
Clin Cancer Res; 2006 Nov; 12(22):6853-62. PubMed ID: 17121907
[TBL] [Abstract][Full Text] [Related]
26. Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT).
Syme R; Stewart D; Rodriguez-Galvez M; Luider J; Auer Y; Klassen J; Morris D; Brown C; Russell J; Glück S
Bone Marrow Transplant; 2003 Aug; 32(3):307-11. PubMed ID: 12858203
[TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
[TBL] [Abstract][Full Text] [Related]
28. A preliminary investigation of the relationship between circulating tumor cells and cancer stem cells in patients with breast cancer.
Wang J; Cao MG; You CZ; Wang CL; Liu SL; Kai C; Dou J
Cell Mol Biol (Noisy-le-grand); 2012 Feb; 58 Suppl():OL1641-5. PubMed ID: 22340707
[TBL] [Abstract][Full Text] [Related]
29. Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Balic M; Lin H; Young L; Hawes D; Giuliano A; McNamara G; Datar RH; Cote RJ
Clin Cancer Res; 2006 Oct; 12(19):5615-21. PubMed ID: 17020963
[TBL] [Abstract][Full Text] [Related]
30. Flow cytometric assessment of monocyte activation markers and circulating endothelial cells in patients with localized or metastatic breast cancer.
Goodale D; Phay C; Brown W; Gray-Statchuk L; Furlong P; Lock M; Chin-Yee I; Keeney M; Allan AL
Cytometry B Clin Cytom; 2009 Mar; 76(2):107-17. PubMed ID: 18727054
[TBL] [Abstract][Full Text] [Related]
31. Urokinase-plasminogen-activator receptor expression in disseminated tumour cells in the bone marrow and peripheral blood of patients with clinically localized prostate cancer.
Thomas C; Wiesner C; Melchior SW; Schmidt F; Gillitzer R; Thüroff JW; Pfitzenmaier J
BJU Int; 2009 Jul; 104(1):29-34. PubMed ID: 19154451
[TBL] [Abstract][Full Text] [Related]
32. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
[TBL] [Abstract][Full Text] [Related]
33. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts.
Vescio RA; Han EJ; Schiller GJ; Lee JC; Wu CH; Cao J; Shin J; Kim A; Lichtenstein AK; Berenson JR
Bone Marrow Transplant; 1996 Jul; 18(1):103-10. PubMed ID: 8832002
[TBL] [Abstract][Full Text] [Related]
34. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
Wimberger P; Heubner M; Otterbach F; Fehm T; Kimmig R; Kasimir-Bauer S
Gynecol Oncol; 2007 Nov; 107(2):331-8. PubMed ID: 17764727
[TBL] [Abstract][Full Text] [Related]
35. Electronic volume of CD34 positive cells from peripheral blood apheresis samples.
Shariatmadar S; Sharma S; Cabana R; Powell S; Ruiz P; Krishan A
Cytometry B Clin Cytom; 2008 May; 74(3):182-8. PubMed ID: 18383271
[TBL] [Abstract][Full Text] [Related]
36. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
37. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
38. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM
Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981
[TBL] [Abstract][Full Text] [Related]
39. Purging breast cancer cells in preparation for autologous bone marrow transplantation.
Morecki S; Pavlotzky F; Margel S; Slavin S
Bone Marrow Transplant; 1987 Apr; 1(4):357-63. PubMed ID: 3332143
[TBL] [Abstract][Full Text] [Related]
40. Tumor cell-selective flow cytometric analysis for DNA content and cytokeratin expression of clinical tumor specimens by "cross-gating".
Park CH; Kimler BF
Anticancer Res; 1994; 14(1A):29-36. PubMed ID: 7513144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
